한국 성인 천식의 진료 지침 - 대한내과학회

천식의 치료 약제 47
었고 반생리적인 호흡법을 이용한 이후의 두 연구에서 증상완화제와 흡입 스테로이드제 사용군
과 유사한 결과를 보였는데 이러한 방법에 의해 환자가 자각하는 호전에는 생리적인 인자가 아
닌 다른 인자가 관여하는 것으로 보인다. 컴프리(comfrey)라는 식물은 약초 차의 형태나 뿌리를
이용한 가루의 형태로 판매되는데 간정맥폐색증을 유발할 수 있어 사용이 금지되고 있다. 이들
에 의한 독성은 pyrrolozodone계 알칼로이드의 존재와 관련이 있다.
••참고문헌
111 Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O’Byrne PM, Hargreave FE. Effect of
long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness
and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 1990;142:832.
222 Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O’Byrne P, Barnes PJ, et al. Effect of
inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids
Establishing Therapy (FACET) International Study Group. N Engl J Med 1997;337:1405.
333 Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the
prevention of death from asthma. N Engl J Med 2000;343:332.
444 Waalkens HJ, Van Essen-Zandvliet EE, Hughes MD, Gerritsen J, Duiverman EJ, Knol K, et
al. Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children
with asthma results in deterioration. The Dutch CNSLD Study Group. Am Rev Respir Dis
1993;148:1252.
555 Dicpinigaitis PV, Dobkin JB, Reichel J. Antitussive effect of the leukotriene receptor antagonist
zafirlukast in subjects with cough-variant asthma. J Asthma 2002;39:291.
666 Drazen JM, Israel E, O’Byrne PM. Treatment of asthma with drugs modifying the leukotriene
pathway. N Engl J Med 1999;340:197.
777 Barnes NC, Miller CJ. Effect of leukotriene receptor antagonist therapy on the risk of asthma
exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast
trials. Thorax 2000;55:478.
888 Lazarus SC, Boushey HA, Fahy JV, Chinchilli VM, Lemanske RF Jr, Sorkness CA, et al. Longacting
beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients
with persistent asthma: a randomized controlled trial. JAMA 2001;285:2583.
999 Shrewsbury S, Pyke S, Britton M. Meta-analysis of increased dose of inhaled steroid or addition
of salmeterol in symptomatic asthma (MIASMA). BMJ 2000;320:1368.
1111 Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to
inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med
1996;153:1481.
1111 Goldstein MF, Fallon JJ Jr, Harning R. Chronic glucocorticoid therapy-induced osteoporosis in
patients with obstructive lung disease. Chest 1999;116:1733.
1111 Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks
and benefits of estrogen plus progestin in healthy postmenopausal women: principal results
From the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321.
1111 Brown JP, Josse RG. 2002 clinical practice guidelines for the diagnosis and management of
osteoporosis in Canada. CMAJ 2002;167:S1.